Maxigesic IV + IV Acetaminophen + IV Ibuprofen + Placebo IV
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post Operative Pain
Conditions
Post Operative Pain
Trial Timeline
Oct 26, 2016 → Sep 15, 2017
NCT ID
NCT02689063About Maxigesic IV + IV Acetaminophen + IV Ibuprofen + Placebo IV
Maxigesic IV + IV Acetaminophen + IV Ibuprofen + Placebo IV is a phase 3 stage product being developed by AFT Pharmaceuticals for Post Operative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02689063. Target conditions include Post Operative Pain.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02689063 | Phase 3 | Completed |
Competing Products
20 competing products in Post Operative Pain
Other Products from AFT Pharmaceuticals
Combogesic® IV (fixed-dose combination containing acetaminophen 10 mg/ml + ibuprofen 3 mg/ml in 100 ml solution for infusion)Phase 3
69
Maxigesic 325 + Acetaminophen + Ibuprofen + PlaceboPhase 3
69
Maxigesic® IVPhase 3
69
Acetaminophen + Maxigesic 325 + Ibuprofen + PlaceboPhase 3
69
Combogesic® tablets + Acetaminophen 500mg + PlaceboPhase 3
69